FLOATING DRUG DELIVERY: A ULTIMATE WAY OF DRUG DELIVERY

Authors

  • Akhilesh Tiwari*, O. P. Mahatma

Abstract

Dosage forms that can be retained in the stomach are called gastroretentive drug delivery systems (GRDDS). GRDDS can improve the controlled delivery of drugs that have an absorption window by continuously releasing the drug for a prolonged period of time before it reaches its absorption site thus ensuring its optimal bioavailability. Gastric emptying of dosage forms is an extremely variable process and ability to prolong and control the emptying time is a valuable asset for dosage forms, which reside in the stomach for a longer period of time than conventional dosage forms. Several difficulties are faced in designing controlled release systems for better absorption and enhanced bioavailability. One of such difficulties is the inability to confine the dosage form in the desired area of the gastrointestinal tract
Floating systems, first described by Davis in 1968, are low-density systems that have sufficient buoyancy to float over the gastric contents and remain in the stomach for a prolonged period. While the system floats over the gastric contents, the drug is released slowly at the desired rate, which results in increased GRT and reduces fluctuation in plasma drug concentration. However besides a minimal gastric content needed to allow proper achievement of the buoyancy retention principle, a minimal level of floating force (F) is also required to keep the dosage form reliably buoyant on the surface of the meal

Downloads

Published

2014-02-23

How to Cite

O. P. Mahatma, A. T. (2014). FLOATING DRUG DELIVERY: A ULTIMATE WAY OF DRUG DELIVERY. Journal of Pharmaceutical Research and Opinion, 1(7). Retrieved from http://innovativejournal.in/index.php/jpro/article/view/689